Biotech stocks down at noon
Wednesday, 11 March, 2009
At 12:30pm the pharmaceuticals index was down 1.3%, bucking the positive overall trend on the ASX which was up almost 2% after big rises on Wall Street overnight.
Index heavyweight CSL (ASX:CSL) accounted for the bulk of the slippage with a drop of 77c to $34.68.
Prana Biotechnology (ASX:PBT) moved up 1.5c, or over 9%, to 17.5c.
Novogen (ASX:NRT) also showed a 6% increase up 2.5c to 45c from yesterday’s lows.
Sigma Pharmaceuticals (ASX:SIP) was down 1% to 95c in light volume.
3D-printed films provide targeted liver cancer treatment
Researchers have created drug-loaded, 3D-printed films that kill more than 80% of liver cancer...
Using your brain at work may ward off cognitive impairment
The harder your brain works at your job, the less likely you may be to have memory and thinking...
Repurposed drugs show promise in heart muscle regeneration
The FDA-approved medications, when given in combination, target two proteins that regulate the...
